Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

October 10, 2015 3:42 AM ET

Healthcare Equipment and Supplies

Company Overview of InSightec Ltd.

Company Overview

InSightec Ltd. Engages in the research, development, manufacture, and marketing of therapeutic magnetic resonance-guided focused ultrasound non-invasive surgery systems. Its magnetic resonance-guided focused ultrasound surgery technology combines a high intensity focused ultrasound beam that heats and destroys targeted tissue non-invasively, as well as visualizes patient anatomy, and controls the treatment by continuously monitoring the tissue effect. The company offers ExAblate O.R., a non-invasive operating room that incorporates interchangeable cradles offering commercially approved and research treatment options for a multitude of clinical indications, such as uterine fibroids, adenomyos...

5 Nahum Heth Street

POB 2059

Tirat Carmel,  39120


Founded in 1999


972 4 813 1313


972 4 813 1322

Key Executives for InSightec Ltd.

Founder and Chief Executive Officer
President and Chief Commercial Officer
Executive Chairman of the Board
Age: 54
Chief Financial Officer and Vice President
Vice President of Operations and Quality
Compensation as of Fiscal Year 2015.

InSightec Ltd. Key Developments

FDA Approves INSIGHTEC's Next Generation Exablate Fibroid Treatment System

INSIGHTEC announced that the United States Food and Drug Administration (FDA) has approved its next generation Exablate system to treat symptomatic uterine fibroids and changed the labeling to allow consideration for women who desire to maintain fertility. The updated labeling specifies that ablation of uterine fibroid tissue can now be considered for women with symptomatic uterine fibroids, who desire to retain fertility and spare their uterus. INSIGHTEC's Exablate therapy platform is transforming medicine by presenting a non-invasive treatment alternative that combines two technologies: Focused Ultrasound, which is used to ablate the fibroid tissue, and Magnetic Resonance Imaging (MRI), which is used to guide the ultrasound waves to the specific target tissue and provide real-time feedback on treatment progress and outcome. This change in labeling provides younger women suffering from symptomatic fibroids access to a new, non-invasive treatment option that is safe, effective and keeps their uterus intact without compromising their existing ability to get pregnant. Theapproval is based on accumulated, documented clinical dataon118 patients'pregnancies post Exablate MRgFUS treatments.

INSIGHTEC Ltd Announces Launch of Neurosurgery System on 1.5T MRI Platform

INSIGHTEC Ltd. announced the expansion of its innovative, non-invasive neurosurgery system from 3T to 1.5T MRI systems. This launch significantly expands the potential market for INSIGHTEC'S ExAblate Neuro as 1.5T systems are the most common MRI systems in use today. The system is immediately available in the European market and is pending regulatory approvals in additional markets. This product expansion is made possible by an INSIGHTEC designed custom imaging coil that improves the intra-operative imaging performance on the 1.5T MRI to allow for this highly precise surgery. The first two treatments were successfully performed in Palermo, Italy led by the Departments of Radiological Sciences at the University Hospital 'Paolo Giaccone' of Palermo and Sapienza University of Rome, School of Medicine, with the collaboration of leading neurosurgeons from both Centro Diagnostico Italiano (CDI) and Istituto Neurologico Carlo Besta of Milano. The system acquisition was made through a research grant from the Italian Ministry of Education and Research.

INSIGHTEC Appoints Maurice R. Ferré as Executive Chairman of the Board

INSIGHTEC announced Dr. Maurice R. Ferré, a seasoned medical device executive, will join the INSIGHTEC leadership team as its newly appointed Executive Chairman of the Board of Directors. Dr. Ferré most recently served as CEO and Chairman of MAKO Surgical Corp.

Similar Private Companies By Industry

Company Name Region
Degania Silicone Ltd. Middle East/Africa
Easy Lap Middle East/Africa
Rapidx Ltd. Middle East/Africa
Venus Concept Ltd. Middle East/Africa
Initia (Medical Technologies) Ltd. Middle East/Africa

Recent Private Companies Transactions

Private Placement
May 25, 2015

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact InSightec Ltd., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at